{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T15:10:37Z","timestamp":1726413037128},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,3,23]],"date-time":"2014-03-23T00:00:00Z","timestamp":1395532800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z. Rheumatol."],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s00393-014-1380-5","type":"journal-article","created":{"date-parts":[[2014,3,21]],"date-time":"2014-03-21T10:49:31Z","timestamp":1395398971000},"page":"465-468","source":"Crossref","is-referenced-by-count":6,"title":["Rituximab zur Therapie des Felty-Syndroms","Rituximab for treatment of Felty\u2019s syndrome"],"prefix":"10.1007","volume":"73","author":[{"given":"H.","family":"Becker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Appel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Fassbinder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Heitzmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Willeke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.M.","family":"Jacobi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,23]]},"reference":[{"key":"1380_CR1","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.berh.2004.05.002","volume":"18","author":"Balint","year":"2004","unstructured":"Balint GP, Balint PV (2004) Felty\u2019s syndrome. Best Pract Res Clin Rheumatol 18:631\u2013645","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"1380_CR2","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1136\/ard.2004.032110","volume":"64","author":"Ghavami","year":"2005","unstructured":"Ghavami A, Genevay S, Fulpius T, Gabay C (2005) Etanercept in treatment of Felty\u2019s syndrome. Ann Rheum Dis 64:1090\u20131091","journal-title":"Ann Rheum Dis"},{"key":"1380_CR3","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1002\/art.10497","volume":"46","author":"Hellmich","year":"2002","unstructured":"Hellmich B, Csernok E, Schatz H et al (2002) Autoantibodies against granulocyte colony-stimulating factor in Felty\u2019s syndrome and neutropenic systemic lupus erythematosus. Arthritis Rheum 46:2384\u20132391","journal-title":"Arthritis Rheum"},{"key":"1380_CR4","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/MOH.0b013e32834760fb","volume":"18","author":"Liu","year":"2011","unstructured":"Liu X, Loughran TP Jr (2011) The spectrum of large granular lymphocyte leukemia and Felty\u2019s syndrome. Curr Opin Hematol 18:254\u2013259","journal-title":"Curr Opin Hematol"},{"key":"1380_CR5","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.3324\/haematol.11819","volume":"92","author":"Mah\u00e9vas","year":"2007","unstructured":"Mah\u00e9vas M, Audia S, De Lastours V et al (2007) Neutropenia in Felty\u2019s syndrome successfully treated with hydroxychloroquine. Haematologica 92:e78\u2013e79","journal-title":"Haematologica"},{"key":"1380_CR6","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.semarthrit.2011.08.008","volume":"41","author":"Narv\u00e1ez","year":"2012","unstructured":"Narv\u00e1ez J, Domingo-Domenech E, G\u00f3mez-Vaquero C et al (2012) Biological agents in the management of Felty\u2019s syndrome: a systematic review. Semin Arthritis Rheum 41:658\u2013668","journal-title":"Semin Arthritis Rheum"},{"key":"1380_CR7","doi-asserted-by":"crossref","unstructured":"Rubbert-Roth A, Tak PP, Zerbini C et al (2010) Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR). Rheumatology (Oxford) 49:1683\u20131693","DOI":"10.1093\/rheumatology\/keq116"},{"key":"1380_CR8","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1136\/ard.2007.077966","volume":"67","author":"Salama","year":"2008","unstructured":"Salama A, Schneider U, D\u00f6rner T (2008) Beneficial response to rituximab in a patient with haemolysis and refractory Felty syndrome. Ann Rheum Dis 67:894\u2013895","journal-title":"Ann Rheum Dis"},{"key":"1380_CR9","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1136\/ard.2004.025643","volume":"64","author":"Sordet","year":"2005","unstructured":"Sordet C, Gottenberg JE, Hellmich B et al (2005) Lack of efficacy of rituximab in Felty\u2019s syndrome. Ann Rheum Dis 64:332\u2013333","journal-title":"Ann Rheum Dis"},{"key":"1380_CR10","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1093\/rheumatology\/37.8.908","volume":"37","author":"Wassenberg","year":"1998","unstructured":"Wassenberg S, Herborn G, Rau R (1998) Methotrexate treatment in Felty\u2019s syndrome. Br J Rheumatol 37:908\u2013911","journal-title":"Br J Rheumatol"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-014-1380-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-014-1380-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-014-1380-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T16:36:18Z","timestamp":1559061378000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-014-1380-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,23]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["1380"],"URL":"https:\/\/doi.org\/10.1007\/s00393-014-1380-5","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"type":"print","value":"0340-1855"},{"type":"electronic","value":"1435-1250"}],"subject":[],"published":{"date-parts":[[2014,3,23]]}}}